IGC Pharma
IGC
#10740
Rank
S$26.43 M
Marketcap
S$0.23
Share price
-4.61%
Change (1 day)
-48.68%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

EPS for IGC Pharma (IGC)

EPS in 2026 (TTM): S-$0.12

According to IGC Pharma's latest financial reports the company's current EPS (TTM) is S-$0.12. In 2025 the company made an earnings per share (EPS) of S-$0.12 an increase over its 2024 EPS that were of S-$0.28.

EPS history for IGC Pharma from 2006 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.12-0.11%
2025S-$0.12-59.09%
2024S-$0.28-0%
2023S-$0.28-26.67%
2022S-$0.3942.86%
2021S-$0.2710.53%
2020S-$0.2446.15%
2019S-$0.17116.67%
2018S-$0.07724-14.29%
2017S-$0.09011-58.82%
2016S-$0.22-45.16%
2015S-$0.40-16.22%
2014S-$0.4815.62%
2013S-$0.41-87.97%
2012S-$3.42-80.15%
2011S-$17.25219.05%
2010S-$5.41740%
2009S-$0.64-91.8%
2008S-$7.85-654.55%
2007S$1.42-178.57%
2006S-$1.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sterling Infrastructure
STRL
S$23.27-20,188.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
S$5.27-4,644.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
S-$7.80 6,633.33%๐Ÿ‡บ๐Ÿ‡ธ USA